DK0701628T3 - Fremgangsmåde til eftersøgning af substanser med modulerende virkning på en interleukin-5-receptorafhængig cellulær signalo - Google Patents

Fremgangsmåde til eftersøgning af substanser med modulerende virkning på en interleukin-5-receptorafhængig cellulær signalo

Info

Publication number
DK0701628T3
DK0701628T3 DK94918807T DK94918807T DK0701628T3 DK 0701628 T3 DK0701628 T3 DK 0701628T3 DK 94918807 T DK94918807 T DK 94918807T DK 94918807 T DK94918807 T DK 94918807T DK 0701628 T3 DK0701628 T3 DK 0701628T3
Authority
DK
Denmark
Prior art keywords
receptor
interleukine
pct
substances
date
Prior art date
Application number
DK94918807T
Other languages
Danish (da)
English (en)
Inventor
Armin Peter Czernilofsky
Ulrike Weyer
Ian G Young
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0701628T3 publication Critical patent/DK0701628T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94918807T 1993-05-27 1994-05-27 Fremgangsmåde til eftersøgning af substanser med modulerende virkning på en interleukin-5-receptorafhængig cellulær signalo DK0701628T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317577A DE4317577A1 (de) 1993-05-27 1993-05-27 Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
PCT/EP1994/001735 WO1994028170A1 (de) 1993-05-27 1994-05-27 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen interleukin-5-rezeptor-abhängigen zellulären signalübertragungsweg

Publications (1)

Publication Number Publication Date
DK0701628T3 true DK0701628T3 (da) 1998-09-21

Family

ID=6488996

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918807T DK0701628T3 (da) 1993-05-27 1994-05-27 Fremgangsmåde til eftersøgning af substanser med modulerende virkning på en interleukin-5-receptorafhængig cellulær signalo

Country Status (17)

Country Link
US (1) US5922549A (fi)
EP (1) EP0701628B1 (fi)
JP (1) JPH08510643A (fi)
KR (1) KR100318188B1 (fi)
CN (1) CN1125467A (fi)
AT (1) ATE162555T1 (fi)
AU (1) AU691816B2 (fi)
CA (1) CA2163549A1 (fi)
DE (2) DE4317577A1 (fi)
DK (1) DK0701628T3 (fi)
ES (1) ES2113109T3 (fi)
FI (1) FI111016B (fi)
HU (1) HU220345B (fi)
NO (1) NO316027B1 (fi)
NZ (1) NZ291131A (fi)
RU (1) RU2139936C1 (fi)
WO (1) WO1994028170A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405350D0 (en) * 1994-03-18 1994-05-04 Sandoz Ltd Organic compounds
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
WO2002028168A1 (en) * 2000-10-03 2002-04-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education High efficiency regulatable gene expression system
AU2003286684A1 (en) * 2002-10-30 2004-06-07 Gail Bishop Somatic cell gene targeting vectors and methods of use thereof
US20040209246A1 (en) * 2003-04-15 2004-10-21 Agouron Pharmaceuticals, Inc. Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
US20050112551A1 (en) * 2003-11-24 2005-05-26 Agouron Pharmaceuticals, Inc. Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
WO1992013063A1 (en) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes
WO1993007294A1 (en) * 1991-10-01 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Service A method of identifying ligands and antagonists of ligands

Also Published As

Publication number Publication date
KR960702532A (ko) 1996-04-27
FI955700A (fi) 1995-11-27
AU6997794A (en) 1994-12-20
WO1994028170A1 (de) 1994-12-08
KR100318188B1 (ko) 2002-06-20
NO316027B1 (no) 2003-12-01
NO954781L (no) 1996-01-23
CN1125467A (zh) 1996-06-26
ATE162555T1 (de) 1998-02-15
ES2113109T3 (es) 1998-04-16
RU2139936C1 (ru) 1999-10-20
HUT73742A (en) 1996-09-30
EP0701628B1 (de) 1998-01-21
CA2163549A1 (en) 1994-12-08
FI955700A0 (fi) 1995-11-27
FI111016B (fi) 2003-05-15
NO954781D0 (no) 1995-11-24
DE4317577A1 (de) 1994-12-01
NZ291131A (en) 1996-10-28
JPH08510643A (ja) 1996-11-12
HU220345B (hu) 2001-12-28
AU691816B2 (en) 1998-05-28
DE59405120D1 (de) 1998-02-26
HU9503363D0 (en) 1996-01-29
EP0701628A1 (de) 1996-03-20
US5922549A (en) 1999-07-13

Similar Documents

Publication Publication Date Title
DK0701628T3 (da) Fremgangsmåde til eftersøgning af substanser med modulerende virkning på en interleukin-5-receptorafhængig cellulær signalo
DK0627002T3 (da) Kloning og ekspression af humaniserede monoklonale antistoffer mod human interleukin-4
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
ATE36413T1 (de) Testverfahren unter verwendung von enzymen als markierungssubstanzen.
AU2945592A (en) Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path
NL300222I1 (nl) Unieke antigene epitopen op igE-dragende B-lymfocyten.
ATE211575T1 (de) Verfahren und system zur informationsübertragung mit verschlüsselungsbetriebsartindikator
CA2167048A1 (en) Identification of ligands by selective amplification of cells transfected with receptors
DE69230146D1 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
ES2057571T3 (es) Receptor de pdgf-alfa.
ATE281647T1 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
ATE377073T1 (de) Modulatoren der funktion des fas/ap01 rezeptors
ATE429486T1 (de) Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten
MX9707881A (es) Sistema desarrollador para marcadores de combustible de petroleo que pueden reaccionar con bases.
ATE366120T1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
Chan et al. Expression of sperm Ca2+‐activated K+ channels in Xenopus oocytes and their modulation by extracellular ATP
NO960715D0 (no) Fremgangsmåter for sceening av anti-östrogen forbindelser
DE69610483D1 (de) In kunstlisches Rekombinantes Substrat rAGG-1 und nativem Aggrecan zum Studium der proteolytischen Wirkung von 'Aggrecanase' in Zellkultursystemen
ATE41529T1 (de) Verfahren zur immunologischen bestimmung einer substanz in einer fluessigen probe.
DE59914992D1 (de) Methode zur zellulären high-throughput-detektion von nukleären rezeptor-liganden-interaktionen
DK439086D0 (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
SE9803398D0 (sv) "New use"
Schnekenburger et al. Protein tyrosine dephosphorylation and the maintenance of cell adhesions in the pancreas
DK0958357T3 (da) Hidtil ukendt fremgangsmåde til testning af differentieringsstatussen i pancreasceller fra et pattedyr
RICHARD Predictions of fracture in the case of cracks exposed to superimposed normal and shear stresses(Bruchvorhersagen bei ueberlagerter Normal- und Schubbeanspruchung von Rissen)